For example, exosome-mediated transfer of miR-3613-5p has been shown to enhance doxorubicin (DOX) resistance in breast cancer cells by inhibiting PTEN, underscoring the importance of miRNA shuttling in modulating treatment outcomes[83]. This evidence concerns the gene PTEN and breast carcinoma.